---
figid: PMC5116860__irdr-5-255-g003
figtitle: Mechanism of action of metformin
organisms:
- Homo sapiens
pmcid: PMC5116860
filename: irdr-5-255-g003.jpg
figlink: /pmc/articles/PMC5116860/figure/F3/
number: F3
caption: Mechanism of action of metformin. Metformin decreases protein synthesis and
  insulin signaling (IS) via the AMPK/Akt/mTOR pathway, it also inhibits the lipid
  and sterol biosynthetic pathways
papertitle: The neurobiology of the Prader-Willi phenotype of fragile X syndrome.
reftext: Zukhrofi Muzar, et al. Intractable Rare Dis Res. 2016 Nov;5(4):255-261.
year: '2016'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.969329
figid_alias: PMC5116860__F3
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC5116860__F3
ndex: 1a0a68b7-dec3-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5116860__irdr-5-255-g003.html
  '@type': Dataset
  description: Mechanism of action of metformin. Metformin decreases protein synthesis
    and insulin signaling (IS) via the AMPK/Akt/mTOR pathway, it also inhibits the
    lipid and sterol biosynthetic pathways
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - PKD2
  - PRKD2
  - PKD1
  - PTEN
  - IARS1
  - IRS1
  - IRS2
  - IRS4
  - PBK
  - MTOR
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - RPS6KB1
  - RPS6KB2
  - EIF4EBP1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EIF4E
  - EIF4E2
  - EIF4E3
  - EPHB2
  - MAPK1
  - MAPK3
  - FMR1
  - TRA-TGC7-1
  - Metformin
  - Mevalonate
  - Squalene
  - Cardiomyopathy
---
